Press releases

FOR IMMEDIATE RELEASE WESTMINSTER, UK. Cambridge Nucleomics, a University of Cambridge spinout pioneering fast molecular diagnostics for actionable insights, today presented evidence to the UK Parliament’s Science, Innovation and Technology Committee. The company highlighted the urgent need for breakthrough sepsis diagnostics and…

Cambridge Nucleomics has successfully closed an oversubscribed £550 k pre-seed round led by Cambridge Angels with participation from Cambridge Technology Capital. In a strong vote of confidence toward Nucleomics' founding team and revolutionary modular soluble nanoarray (MSN) technology platform, this capital injection…

Cambridge Nucleomics is proud to be awarded the 2025 Trinity Bradfield Angel Prize jointly with BioTryp Therapeutics in recognition of achievements over the past 12 months. The prize was evaluated and awarded by a distinguished panel of scientific experts, industry leaders and…

Cambridge Nucleomics is honoured to have won the prestigious 2024 Trinity Bradfield Prize. Awarded by Nobel laureate and serial entrepreneur Sir Greg Winter, this prize provided crucial early-stage validation for our vision to break the diagnostic bottleneck in molecular testing. Over the…